Abstract
Introduction
Alterations of cytosolic Ca 2+ activity ([Ca 2+ ] i ) participate in the regulation of a wide variety of cellular functions, such as cell proliferation, migration, excitation, exocytosis, and cell death [1] [2] [3] [4] [5] . Mechanisms regulating [Ca 2+ ] i include Ca 2+ release from intracellular stores and subsequent activation of store-operated Ca 2+ entry (SOCE). Molecular mechanisms accomplishing SOCE include the pore-forming Ca 2+ channel subunits Orai1, Orai2 and/or Orai3 [6] [7] [8] [9] [10] as well as their regulators STIM1 and/or STIM2 [11] [12] [13] [14] [15] ] i oscillations with subsequent activation of Ca 2+ dependent transcription factors and reorganization of the actin filament network [25] . In tumor cells Ca 2+ signaling may contribute to therapy resistance [26] . A recent study revealed that in MCF-7 breast tumor cells, Ca 2+ release, SOCE, and Na + / Ca 2+ exchanger activity are all sensitive to pharmacological inhibition of the Janus kinase 2 [27] . In other cell types, Ca 2+ release, SOCE, and Na + /Ca 2+ exchanger activity are modified by the Janus kinase isoform JAK3 [28] .
The present study thus explored whether pharmacological inhibition of JAK3 by WHI-P154 similarly influences Ca 2+ signaling in MCF-7 breast carcinoma cells.
Materials and Methods

Cell culture
Experiments were performed in MCF-7 breast carcinoma cells cultured in DMEM containing 10% fetal calf serum and 1% antibiotic/antimycotic solution. Where indicated the cells were treated with JAK3 inhibitor WHI-P154 (Tocris, USA) [27] .
Real-time PCR
Total RNA was extracted from MCF-7 breast carcinoma cells in TriFast (Peqlab, Erlangen, Germany) according to the manufacturer's instructions [29] . After DNAse digestion reverse transcription of total RNA was performed using Transcriptor High Fidelity cDNA Synthesis Kit (Roche Diagnostics, Penzberg, Germany). Real-time polymerase chain reaction (RT-PCR) of the respective genes were set up in a total volume of 20 µl using 40 ng of cDNA, 500 nM forward and reverse primer and 2x GoTaq® qPCR Master Mix (Promega, Mannheim, Germany) according to the manufacturer's protocol. Cycling conditions were as follows: Initial denaturation at 95°C for 2 min, followed by 40 cycles of 95°C for 15 sec, 58°C for 15 sec and 68°C for 20 sec. For amplification the following primers were used (5`>3`orientation):
for Orai1: fw: CGTCCACAACCTCAACTCC; rev: AACTGTCGGTCCGTCTTAT; for NCX1: fw: CTGGAATTCGAGCTCTCCAC; rev: GGCATCATGGAGGTGAAAGT; for Tbp: fw: ACTCCTGCCACACCAGCC; rev: GGTCAAGTTTACAGCCAAGATTCA Specificity of PCR products was confirmed by analysis of a melting curve. Real-time PCR amplifications were performed on a CFX96 Real-Time System (Bio-Rad, Munich, Germany) and all experiments were done in duplicate. The house-keeping gene Tbp (TATA binding protein) was amplified to standardize the amount of sample RNA. Relative quantification of gene expression was achieved using the ΔCT method as described earlier [29, 30] .
Ca
2+ measurements Fura-2 fluorescence was utilized to determine intracellular Ca 2+ measurements [31] . Cells were loaded with Fura-2/AM (2 µM, Invitrogen, Goettingen, Germany) for 20 min at 37°C. Cells were excited alternatively at 340 nm and 380 nm through an objective (Fluor 40×/1.30 oil) built in an inverted phasecontrast microscope (Axiovert 100, Zeiss, Oberkochen, Germany). Emitted fluorescence intensity was recorded at 505 nm. Data were acquired using specialized computer software (Metafluor, Universal Imaging, Downingtown, USA). Cytosolic Ca 2+ activity was estimated from the 340 nm/380 nm ratio. SOCE was determined by extracellular Ca 2+ removal and subsequent Ca 2+ re-addition in the presence of thapsigargin
(1 µM, Invitrogen) [32] . For quantification of Ca 2+ entry, the slope (delta ratio/s) and peak (delta ratio) were calculated following re-addition of Ca 2+ [31, 33] . Experiments were performed with Ringer solution containing (in mM): 125 NaCl, 
Statistical analysis
Data are provided as means ± SEM; n represents the number of independent experiments. All data were tested for significance using Student's unpaired two-tailed t-test, one sample t-test or ANOVA (Dunnett's test), where applicable. Results with p<0.05 were considered statistically significant.
Results
Fura2-fluorescence was taken as measure of cytosolic Ca
2+ activity ([Ca   2+ ] i ). In order to test whether the JAK3 inhibitor WHI-P154 (22 µM) influences agonist-induced increase of [Ca 2+ ] i , the effect of purinergic receptor agonist ATP in the presence of extracellular Ca 2+ was tested. As illustrated in Fig. 1 , addition of ATP (100 µM) in the presence of extracellular Ca 2+ was followed by an increase of Fura-2 fluorescence ratio. Amplitude (peak, ∆ ratio) and velocity (slope, ∆ ratio/s) were both significantly less pronounced in WHI-P154 (22 µM, 24 h) treated than untreated MCF-7 cells (Fig. 1) /ATPase (SERCA) inhibitor thapsigargin (1 µM) followed by re-addition of extracellular Ca 2+ in the continued presence of thapsigargin. The Fura2-fluorescence ratio prior to extracellular Ca 2+ removal was similar in untreated (0.33 ± 0.04, n = 41) and WHI-P154-treated (22 µM, 24 h) (0.32 ± 0.03, n =39) MCF-7 cells. As illustrated in Fig. 2 , the addition of thapsigargin triggered Ca 2+ release from intracellular stores, leading to rapid, transient increase in [Ca 2+ ] i . The increase of intracellular Ca 2+ activity following thapsigargin treatment was similar in WHI-P154 treated and in untreated MCF-7 carcinoma cells (Fig. 2) . The addition of extracellular Ca 2+ in the continued presence of thapsigargin was followed by a rapid increase of Fura2-fluorescence in both, treated and untreated cells reflecting store operated Ca 2+ entry (SOCE). Both, peak and slope of SOCE were significantly lower in WHI-P154-treated than in untreated MCF-7 carcinoma cells (Fig. 2) .
RT-PCR was employed to explore whether the effect of WHI-P154 on SOCE was paralleled by a respective modification of the Orai1 transcript levels. The effect of JAK3 inhibitor WHI-P154 is shown in Fig.3 . A 24 hours treatment with WHI-P154 (22 µM) significantly decreased the Orai1 transcript levels. A further series of experiments addressed the putative effect of WHI-P154 (22 µM) on Ca 2+ extrusion by Na + /Ca 2+ exchange. The changes in cytosolic Ca 2+ activity upon removal of extracellular Na + were taken as a measure of Na + /Ca 2+ exchange. As illustrated in Fig. 4 , removal of extracellular Na + was followed by an increase of cytosolic Ca 2+ activity in treated and untreated MCF-7 cells. The effect was, however, significantly larger in WHI-P154 treated cells than in untreated cells.
RT-PCR was employed to test whether the JAK3 inhibitor WHI-P154 influences the transcript levels of NCX1. As shown in Fig. 5 , a 24 h treatment with WHI-P154 (22 µM) significantly increased the NCX1 transcript levels.
Discussion
The present study reveals that WHI-P154, an inhibitor of Janus-activated kinase JAK3 [25] . The Ca 2+ oscillations thus contribute to the regulation of diverse cellular functions [17, [35] [36] [37] [38] including entering into the S and the M phase of the cell cycle [39, 40] and cell survival [41, 42] . Sustained increases of cytosolic Ca 2+ activity are known to trigger apoptosis [36, 38, [43] [44] [45] [46] [47] [48] [49] [50] [51] . Orai and NCX dependent Ca 2+ oscillations are further instrumental in the stimulation of cell migration [52] [53] [54] . Accordingly, Orai1, 2, or 3 [6] [7] [8] [9] , their regulators STIM 1 or 2 [12, 13, 15] and Na + /Ca 2+ exchangers [55] are involved in the regulation of survival, proliferation, and migration of tumor cells [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] .
JAK3 has previously been shown to participate in the regulation of a variety of further channels [70] [71] [72] [73] [74] [75] [76] [77] , transporters [78] [79] [80] [81] and the Na + /K + ATPase [82] . The present study sheds additional light on the function of JAK3 as a transport regulating kinase.
In conclusion, the JAK3 inhibitor WHI-P154 decreases both store operated Ca 2+ entry (SOCE) and Ca 2+ extrusion by Na + /Ca 2+ exchange, an effect possibly reflecting an involvement of JAK3 in the regulation of Orai1 and NCX1 transcription.
